Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Median TechnologiesXPAR:ALMDT -3.75%49 Median PS Value is €4.19 as of Jul. 18, 2026, which is 100% below its 10-year median of 0.33. GuruFocus rates XPAR:ALMDT with a GF Score™ of 49/100 and a GF Value™ of €1.73 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 336 Medical Devices & Instruments companies, Median Technologies ranks worse than 77.08% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Median Technologies's Median PS Value or its related term are showing as below:
XPAR:ALMDT'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.17 Med: 0.33 Max: 1.13
Current: 0.98
During the past 13 years, the highest Price to Median PS Value of Median Technologies was 1.13. The lowest was 0.17. And the median was 0.33.
XPAR:ALMDT's Price-to-Median-PS-Value is ranked worse than 77.08% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs XPAR:ALMDT: 0.98
Median Technologies (XPAR:ALMDT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Median Technologies's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
4.11
/
4.19
=
0.98
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Median Technologies Median PS Value Related Terms
Median Technologies Median PS Value Historical Data
* Premium members only.
The historical data trend for Median Technologies's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALMDT vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, Median Technologies's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Median Technologies Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Median Technologies's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Median Technologies's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 5.5644.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Median Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.753.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Median Technologies (XPAR:ALMDT) has a Median PS Value of €4.19 as of Jul. 18, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Median Technologies and its competitors. This is 1170% above median its historical median of 0.33. Over the past decade, Median Technologies' Median PS Value has ranged from 0.17 to 1.13. According to the industry distribution chart, Median Technologies ranks #259 out of 336 companies in the Medical Devices & Instruments industry, placing it in the top 77.1%.
Is Median Technologies' Median PS Value too high?
Median Technologies' current Median PS Value of €4.19 is 1170% above median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 1.13. Based on the distribution chart, Median Technologies ranks #259 out of 336 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Median Technologies has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Median Technologies' Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Median Technologies ranks #259 out of 336 companies for Median PS Value. This places Median Technologies in the lower half of its industry. The industry median Median PS Value is 0.71. Historically, Median Technologies' own Median PS Value has ranged from 0.17 to 1.13 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Median Technologies and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Median Technologies's current Median PS Value is €4.19, which is 1170% above median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Median Technologies stock overvalued right now?
Based on GuruFocus' analysis, Median Technologies (XPAR:ALMDT) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.73, compared to a current price of €4.11 — trading 137.6% above its estimated fair value. The current Median PS Value is €4.19, which is 1170% above median its 10-year median of 0.33. Median Technologies' overall GF Score™ is 49/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Median Technologies (XPAR:ALMDT), the current Median PS Value is €4.19 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Median Technologies (XPAR:ALMDT) Overvalued in 2026?
Based on GuruFocus' analysis, Median Technologies stock appears to be overvalued.
The current stock price of €4.11 is trading 137.6% above its estimated GF Value™ of €1.73.
GuruFocus considers Median Technologies to be Significantly Overvalued.
Key valuation signals for XPAR:ALMDT:
Median PS Value: €4.19 (1170% above median its 10-year median of 0.33)
GF Value™: €1.73 vs. price of €4.11 (137.6% above fair value)
No single metric tells the full story. See the XPAR:ALMDT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The company focuses on the oncology clinical trials market and the cancer patient care market. The company has two platforms, iSee for imaging services in clinical trials and eyonis for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer. Its revenue is generated from contracts for providing imaging services for oncology clinical trials using dedicated software. Geographically, the company generates revenue from EMEA, the USA/Canada, and China.
49GF Score
Get the complete analysis for XPAR:ALMDT
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALMDT has been successfully added to your 
